CRT-107 Abbreviated versus Standard Eptifibatide Infusion in ST Elevation Myocardial Infarction- Outcomes and Predictors of Complications
| Autor: | Kerrett Wallace, Seeger Shen, Farrukh Hussain, Steve Promislow, Chris Haye, Alireza Bagherli |
|---|---|
| Jazyk: | angličtina |
| Předmět: |
medicine.medical_specialty
Adverse outcomes business.industry medicine.disease St elevation myocardial infarction Internal medicine cardiovascular system Eptifibatide medicine Cardiology cardiovascular diseases Myocardial infarction business Cardiology and Cardiovascular Medicine Major bleeding medicine.drug |
| Zdroj: | JACC: Cardiovascular Interventions. (2):S10 |
| ISSN: | 1936-8798 |
| DOI: | 10.1016/j.jcin.2014.12.037 |
| Popis: | Glycoprotein IIb/IIIa inhibition has been a mainstay in acute myocardial infarction intervention. Major bleeding is a predictor of adverse outcomes in ST elevation myocardial infarction (STEMI). To determine the safety and bleeding outcomes of abbreviated compared to standard infusions of the |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|